Johnson Research Group

Johnson Research Group

The Johnson Research Group LLC (JRG) is dedicated to providing investors with one thing – an edge. We know there’s no “holy grail” or “magic bullet” in investing. And we’re well aware that savvy investors know that, too. With that truth in mind, our mission is to create an edge so our followers can become more successful traders and investors.

How do we create that edge? With innovative research, a unique analytical approach and the experience to translate our edge into your investing success. JRG is dedicated to providing the highest-quality research and outstanding trading performance. We realize your success is our success. And we’ll do everything we can to make you a more successful investor.

JRG provides timely market commentary on stocks, ETFs and major indices as well as insight on activities in the equity options market. In addition to delivery through a number of media partnerships, JRG’s content and commentaries are also carried by major news television, on radio and in print.

JRG analysts are frequent commentators on financial markets and represent the firm at national investment conferences. The firm’s comments are regularly seen in national print media, such as Barron’s, Los Angeles Times, Washington Post, The Wall Street Journal, USA TODAY and on the AP Newswire.

In addition to being a guest on several radio shows, Mr. Johnson and other representatives appears regularly on CNBC, Bloomberg TV and Fox News Channel as an expert in the field of sentiment and investor behavior, as well as technical analysis.

Recent Articles

3 Hot Stocks That Are About to Break the Shorts

The shorts are betting on the wrong horses. High short interest in these three stocks will have the bulls enjoying the benefits of short squeezes soon enough.

3 Short Squeezes Just Waiting to Burst (ACN, DRI, JAH)

These three short squeeze plays offer the perfect combination of strong technical trends, relative strength and a host of very misled bears.

3 Explosive Biotech Stocks to Buy Once the Dust Clears

These three biotech stocks to buy will likely take a bruising in coming weeks, but their pain will become investors' gain soon enough.

3 Bank Stocks That Will Leave the Market in Its Dust

The analysts don't love these bank stocks right now ... but when interest rates rise, they'll be forced to play catch-up, driving shares even higher.

4 Retail Stocks to Buy Now

We expect these so-called 'tier two' retail stocks to buy to at least double the returns of the S&P 500 in the next six months.